NEWMONT CORPORATION Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing
NEWMONT CORPORATION (NEMCL) reported Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing of $3.00 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2014-07-30.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting · last filed 2014-07-30
- NEWMONT CORPORATION derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2013-06-30 was $3.00M, a 50.00% increase year-over-year.
- NEWMONT CORPORATION derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2013-03-31 was -$3.00M.
- NEWMONT CORPORATION derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2012-06-30 was $2.00M.
- NEWMONT CORPORATION derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2012-03-31 was -$2.00M, a 300.00% decline year-over-year.
- NEWMONT CORPORATION derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for fiscal 2010 was $2.00M.
| Period end | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 6 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 9 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 12 month |
|---|---|---|---|---|
| 2013-06-30 | $3.00M 10-Q · filed 2014-07-30 | $0.00 10-Q · filed 2013-07-26 | ||
| 2013-03-31 | -$3.00M 10-Q · filed 2014-04-25 | |||
| 2012-12-31 | -$2.00M 8-K · filed 2014-06-13 | |||
| 2012-06-30 | $2.00M 10-Q · filed 2013-07-26 | $0.00 10-Q · filed 2013-07-26 | $5.00M derived: sum of 3 quarters · filed 2014-06-13 | $15.00M derived: sum of 4 quarters · filed 2014-06-13 |
| 2012-03-31 | -$2.00M 10-Q · filed 2013-04-30 | $3.00M derived: sum of 2 quarters · filed 2014-06-13 | $13.00M derived: sum of 3 quarters · filed 2014-06-13 | |
| 2011-12-31 | $5.00M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-13 | $15.00M derived: sum of 2 quarters · filed 2014-06-13 | $17.00M 8-K · filed 2014-06-13 | |
| 2011-09-30 | $10.00M 10-Q · filed 2011-10-27 | $12.00M 10-Q · filed 2011-10-27 | ||
| 2011-03-31 | $1.00M 10-Q · filed 2012-04-26 | |||
| 2010-12-31 | $2.00M 10-K · filed 2013-02-22 | |||
| 2010-09-30 | $0.00 10-Q · filed 2011-10-27 | $1.00M 10-Q · filed 2011-10-27 |